Fitness Trackers During and After Oncological Treatments

University Hospital Tuebingen50 enrolled

Overview

The overall goal of the present trial is to evaluate the patients' compliance for wearing a commercially available fitness tracker during and after oncological treatments.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Cancer Physical Activity Fatigue

Interventions

Fitness TrackerDEVICE

Patients will continuously wear a commercially available fitness tracker which will collect data on physical activity (steps), pulse rate and sleep behaviour.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histologically confirmed malignant disease * Upcoming chemotherapy of radiochemotherapy * Eastern Co-operative Oncology Group (ECOG) performance score 0-2 Exclusion Criteria: * Pre-existing comorbidities that impair patient mobility. * Eastern Co-operative Oncology Group (ECOG) performance score 3-4

Locations (1)

University Hospital Tübingen

Tübingen, Germany

RECRUITING

Outcomes

Primary Outcomes

Compliance for wearing the fitness tracker

Based on the read outs from the fitness trackers we will calculate the percentage of the days on which the tracker was worn, which is defined as the compliance.

Time frame: Four weeks after the end of radiotherapy

Central Contacts

Cihan Gani, MD

CONTACT

+4970712982165 cihan.gani@med.uni-tuebingen.de

Silke Theden

CONTACT

+4970712983420 silke.theden@med.uni-tuebingen.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.